Skip to main content
HR 3697 110th Congress House Health Animals Bacterial diseases Business records Commerce Congress Congressional investigations Congressional reporting requirements Department of Health and Human Services Drug industry Drug resistance in microorganisms Drugs Economics and Public Finance Epidemiology Executive reorganization Federal advisory bodies Federal aid to research Government Operations and Politics Government paperwork Government publicity

Strategies to Address Antimicrobial Resistance Act

Introduced: September 27, 2007 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 8, 2007
Referred to the Subcommittee on Health.
Sep 27, 2007
Referred to the House Committee on Energy and Commerce.
Sep 27, 2007
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to: (1) establish, and appoint the Director of, the Office of Antimicrobial Resistance in the Office of the Assistant Secretary for Health to develop plans for addressing antimicrobial resistance in the United States and internationally; (2) establish the Public Health Antimicrobial Advisory Board to assist the Director; and (3) develop an antimicrobial resistance strategic research plan. Renews the Antimicrobial Resistance Task Force and sets forth its membership and duties.

Requires sponsors of human and animal antimicrobial drug products to report to the Office of Antimicrobial Resistance the amount of such drug products sold or distributed in the United States in a calendar year. Requires the Director to make summaries of drug distribution data publicly available.

Requires the Secretary to: (1) establish at least 10 Antimicrobial Resistance Clinical Research and Public Health Network sites to describe outbreaks of antimicrobial resistant pathogens and monitor the patterns of such pathogens in individuals; and (2) award competitive grants to establish demonstration projects to assess the scope of the antimicrobial resistance problem and the use of antimicrobial drugs.

Requires the Comptroller General to report to Congress on the effectiveness of this Act.

What's happening now November 8, 2007

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 2313 Related bill Strategies to Address Antimicrobial Resistance Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 5
All 5 Democratic 5
D
Lynch, Stephen F.
Massachusetts · Jul 10, 2008
 D
Carson, André
Indiana · May 19, 2008
 D
Cuellar, Henry
Texas · Feb 13, 2008
 D
McCollum, Betty
Minnesota · Dec 4, 2007
 D
Baldwin, Tammy
Wisconsin · Sep 27, 2007
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3697: Strategies to Address Antimicrobial Resistance Act. 110th Congress. Open America. https://openamerica.io/bill/110-HR-3697/
MLA
"H.R. 3697: Strategies to Address Antimicrobial Resistance Act." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HR-3697/.
Bluebook (legal)
H.R. 3697, 110th Cong. (2026), https://openamerica.io/bill/110-HR-3697/.
Markdown link
[H.R. 3697: Strategies to Address Antimicrobial Resistance Act](https://openamerica.io/bill/110-HR-3697/)
Report a problem